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Franco Ciulli, FRCS, Jamie Y. Jeremy, PhD, and Gianni D. Angelini, FRCS, Bristol, United KingdomDespite a significantly lower incidence of wound infection
rates1 and compelling evidence that there is no difference
in the degree of preservation of histologic architecture,
vascular tone, or vasomotor reactivity of veins harvested
with the Mayo dissector (Johnson and Johnson, Langhorne,
PA) and a similar graft patency compared with the open
method,2 use of the Mayo dissector still remains limited,
probably because of a lack of evidence regarding the
functional quality of the vein. In modern practice, although
endoscopic vein harvest is gaining popularity, the Mayo
dissector (Figure 1) still remains a satisfactory and inexpen-
sive, albeit underused, alternative for vein harvesting, and
hence we sought to examine the functional quality of the
veins harvested with the Mayo extraluminal dissector.
Nitric oxide (NO), a vasoactive molecule produced from
the endothelium, is a marker of endothelial function. NO
is associated with a diminished incidence of neointimal pro-
liferation, producing these effects through stimulation of sol-
uble guanylate cyclase and generation of cyclic guanosine
monophosphate (cGMP). To compare the functional ability
of harvested saphenous veins with the Mayo stripper and
conventional open dissection, we measured cGMP produc-
tion ex vivo after stimulation with specific activators of the
NO–cGMP axis.
CLINICAL SUMMARY
After obtaining informed consent, a consecutive series of
32 patients (25 male patients; age range, 46–80 years; me-
dian, 67 years) undergoing coronary artery bypass grafting
were prospectively randomized into one of 2 groups to
have their saphenous veins harvested either by means of
conventional open dissection or with a Mayo dissector.
This was carried out by residents of similar surgical experi-
ence and expertise.
Harvesting of veins by means of the open technique was
performed in the standard manner. In all cases, dissection
was started at the distal end of the vein. A 10-cm incision
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incision was then extended onto the skin with McIndoe scis-
sors. Care was taken to ensure minimal handling of the vein,
holding only the adventitia for mobilizing the vein. Branches
were ligated with a medium clip (Horizon medium titanium
clips; Weck, High Wycombe, United Kingdom) or with
4-0 coated, braided silk (USS/DG UMECO Inc, San Juan,
Puerto Rico) sutures. The subcutaneous fat was closed in 1 or
2 layers with 2-0 polyglactin 910 vieryl (Ethicon, Inc, Somer-
ville, NJ) sutures, and the skin was sutured with subcuticular
coated, undyed 3-0 Vicryl sutures. On average, 15 to 18 cm
of vein was harvested for each coronary artery to be bypassed.
Subcutaneous harvesting was performed with an extralu-
minal vein dissector (Mayo vein stripper; Johnson and
Johnson, Langhorne, Pa) and started at the proximal end in
the groin. After the vein was suture ligated and divided from
the saphenofemoral junction, it was dissected free from
surrounding tissues, and its branches were clipped on the pa-
tient’s side and cut. The vein was then brought out through
a more distal incision with the help of the Mayo stripper.
Through multiple incisions along the course of the long sa-
phenous vein, the desired length of the vein was harvested.
Care was taken to minimize traction on the vein, and the vein
was periodically soaked with heparinized saline to prevent
desiccation. Once the vein was harvested, the side branches
were secured with medium titanium clips (Horizon medium
titanium clips, Weck) or with 4-0 silk sutures.
A 2- to 3-cm-long segment of undistended vein was
placed in Krebs–Ringer bicarbonate buffer pregassed with
oxygen/carbon dioxide, transported to the laboratory, and
then cut into rings and placed in Krebs–Ringer bicarbonate
buffer containing 250 mmol of isobutylmethyl xanthine to
inhibit phosphodiesterase activity and breakdown of
FIGURE 1. The Mayo extraluminal vein dissector.rgery c August 2009
Brief Technique ReportscGMP. The basal cGMP levels were measured, and the fol-
lowing stimulators were added. First, sodium nitroprusside
activates guanylcyclase directly, bypasses the release of
NO from the endothelium, and is therefore an index of
cGMP-synthesizing capacity. Second, A2387, a calcium
ionophore, increases calcium levels in the endothelium,
thereby activating NO synthase (NOS), and is therefore an
index of endothelial NOS activity and an index of endothe-
lial integrity. Finally, acetylcholine generates inositol tri-
phosphate, which stimulates calcium mobilization, thereby
activating endothelial NOS and NO formation. Because ace-
tylcholine classically activates NOS in endothelial cells, it is
therefore an index of endothelial integrity.
After incubation at 37C for 30 minutes, reactions were
stopped with perchloric acid and extracted, and cGMP levels
were measured with specific cGMP radioimmunoassays.
Baseline characteristics were similar in the 2 groups
(Table 1). The basal cGMP production was similar between
conventional vein harvesting and use of the Mayo dissector
(2.65  1.408 vs 2.875  0.806 fmol/mg of tissue per min-
ute; P ¼ .54; 95% confidence interval,1.079 to 579). Pro-
duction of cGMP after stimulation with acetylcholine,
sodium nitroprusside, and A23187 was also similar across
the 2 groups (Table 2).
DISCUSSION
Thrombosis and neointimal hyperplasia in the early post-
operative period and atherosclerosis in the late postoperative
period are the primary causes of vein graft failure.3 Loss of
endothelium eliminates the physical and electrostatic barrier
separating platelets from subendothelial collagen, binding to
which initiates platelet activation and resultant thrombotic
occlusion. Endothelial loss is also associated with neointi-
TABLE 1. Baseline characteristics
Conventional
vein harvest
(n ¼ 16)
Vein harvest with
the Mayo stripper
(n ¼ 16)
n % n % P value
Hypertension 11 68.7 10 62.5 .7
Peripheral vascular disease 3 18.7 4 25.0 .6
Diabetes
Not diabetic 12 75.0 14 87.5 .17
IDDM 1 6.25 2 12.5
NIDDM 3 18.7 0 0
Smoking status
Never smoked 6 37.5 3 18.7 .12
Current smoker 2 12.5 0 0
Exsmoker 8 50.0 13 81.2
LV function
Good 13 81.2 8 50.0 .15
Moderate 3 18.7 7 43.7
Poor 0 0 1 6.2
IDDM, Insulin-dependent diabetes mellitus; NIDDM, non–insulin-dependent diabetes
mellitus; LV, left ventricular.The Journal of Thoracic and Cmal hyperplasia and results in reduced production of NO.4
NO has an important role in the prevention of vein graft fail-
ure.5 Apart from being a potent vasodilator and possessing
antiplatelet activity, NO limits neointimal hyperplasia by in-
hibiting smooth muscle cell proliferation and induces cell
death by means of apoptosis.
Irrespective of the agonist used, this study demonstrates
that there was no difference in cGMP production between
the 2 groups. In turn, this indicates that the relative amount
of endothelium and production of NO does not differ be-
tween the 2 groups. Moreover, although loss of endothelium
and NO might be axiomatic in mediating vein graft failure,
a host of factors, such as distension pressure, storage temper-
ature and solutions, target vessel diameter, and surgical tech-
nique, all play an important role.5-8
With respect to leg wound infections, minimally invasive
techniques, such as the Mayo extraluminal dissector and
endoscopic vein-harvesting techniques, have been shown
to reduce the incidence of theses complications signifi-
cantly.2,9 Both techniques, however, differ in terms of sur-
gical approach and are rather different in terms of cost.
Unlike the Mayo dissector technique, in which vein har-
vesting is initiated in the groin, endoscopic vein harvesting
with the VasoView endoscopic system (Origin Medsystems,
Menlo Park, Calif) is started with an incision at the medial
aspect of the knee. Blunt dissection, carbon dioxide insuffla-
tion at a pressure of 12 to 15 mm through an insufflation
port, and balloon inflation can all be used to aid the proce-
dure. Bipolar scissors are used commonly to ligate the
vein tributaries, an additional proximal incision at the ankle
and a distal incision at the groin are made, and the desired
length of vein is harvested.10
However, the more important difference is in terms of the
financial burden. The endoscopic vein-harvesting technique
uses a disposable system that can cost from $450 to $550 per
patient, to which must be added the initial cost of setup of
video monitors and cameras.10 On the other hand, the
Mayo dissector is a reusable instrument of negligible cost.
In light of the findings of our own study and data from the
available literature, we conclude that use of the Mayo
TABLE 2. cGMP production after stimulation with NO–cGMP axis
activators
Conventional
vein harvest*
Vein harvest
with the Mayo
Stripper*
P
value
Acetylcholine (1 mm) 4.44  1.54 4.63  0.95 .6
Acetylcholine (10 mm) 9.93  4.07 11.81  4.76 .2
Sodium nitroprusside (1 mm) 21.25  6.63 20.12  4.25 .5
Sodium nitroprusside (10 mm) 79.81  20.15 77.31  13.44 .6
A23187 (1 mm) 5.43  1.99 5.75  1.69 .6
A23187 (10 mm) 11.37  4.78 13.18  4.66 .2
cGMP, Cyclic guanosine monophosphate; NO, nitric oxide. *Data are reported as
means  standard deviation. Values are presented as femtomoles per milligram of
tissue per minute.ardiovascular Surgery c Volume 138, Number 2 509
Brief Technique Reportsextraluminal vein stripper preserves endothelium in a similar
fashion as conventional vein harvest. This, coupled with the
established superiority of the Mayo stripper in reducing
postoperative leg wound infections, the short learning curve,
and no additional financial implications, makes the use of
this underused surgical aid from the past a very attractive
option, even in the modern era.
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Minimally invasive cardiac valvular surgery is associated
with decreased pain, reduced blood loss, faster recovery,
superior cosmetic results, and greater patient satisfaction
when compared with sternotomy approaches. Despite
this, these techniques have rarely been used for intracardiac
tumor resections, which have traditionally been performed
through a median sternotomy. Tumors situated in the left
ventricular apex represent a surgical challenge because it
is a difficult area to access without a left ventriculotomy
and its attendant complications. A recent report in the Jour-
nal describes the use of a thoracoscopic transaortic ap-
proach to resect a left ventricular fibroelastoma through
a median sternotomy.1 To combine a thoracoscopic instru-
ment with a median sternotomy seems paradoxical, and
therefore we describe a truly minimally invasive approach
to an apical left ventricular myxoma that we have used in-
volving a thoracoscopic approach combined with a right
anterior minithoracotomy.
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CLINICAL SUMMARY
A 65-year-old asymptomatic man, while undergoing
echocardiographic work-up for a cardiac murmur, was
discovered to have a 12-mm 3 9-mm tumor at the junction
of the mid and apical lateral segments of the left ventricle
(Figure 1, A). There was no significant valvular disease
nor was there any history of thromboembolic events. There
was no significant coronary disease. He was referred for sur-
gical excision, which was accomplished with a minimally
invasive technique.
A left-sided, double-lumen endotracheal tube and a 17F
right internal jugular–superior vena cava Bio-medicus can-
nula (Medtronic, Inc, Minneapolis, Minn) were positioned.
The right chest was elevated 20, and a 5-cm right anterior
(second intercostal space) minithoracotomy was made just
lateral to the right internal thoracic artery. A soft tissue retrac-
tor (Cardiovations; Edwards Lifesciences, Irvine, Calif) was
deployed, and a pericardial well was created. A 5-mm video-
scope port was positioned lateral to the incision, and a voice-
activated robotic arm was used for camera manipulation
(AESOP 3000; Computer Motion, Inc, Galeta, Ca). The
operative field was flooded with carbon dioxide (4 L/min).
The femoral vessels were cannulated through a 2-cm
groin incision with the Seldinger guidewire–transesopha-
geal echocardiographic visualization method (arterial:
17F–19F cannula, venous: 22F–25F long multistage cannula).
After commencing vacuum-assisted cardiopulmonary bypass,
rgery c August 2009
